Child and adolescent psychiatry panel
Board-certified child and adolescent psychiatrists.
Scope
Age-specific considerations on ADHD medication pages, SSRI use in pediatric populations, guanfacine and clonidine for pediatric ADHD, and the boxed-warning content on antidepressants in youth.
Pages owned by this panel
Current members
This panel currently has 1 named seat open. No specialist reviewer has joined yet.
A reviewer's name only appears on this page after they have (a) agreed in writing to participate and (b) reviewed and approved at least one page in the scope above. We do not pad panels with unaffiliated names.
Join this panel
If you are a board-certified specialist in child and adolescent psychiatry and would like to review pages in the scope above, see the contribute page for the full application process, or email [email protected] with the subject line "Child and adolescent psychiatry panel: application."
Reviewers receive: a public profile page at /reviewers/<your-slug>/, named credit on every page they review, a shareable badge for their institutional bio or CV, and a canonical inbound link from PsychiatryRx to their broader academic identity. Reviewers do not receive compensation, referral revenue, or any commercial relationship with the site.